October 11-15, 2023
Biolexis Therapeutics Scientific Team participates and present their IND stage small molecule CDK9 inhibitor program for Pancreatic Cancers indications at The “AACR-NCI-EORTC” International Conference on Molecular Targets and Cancer Therapeutics to be held on Oct 11-15, 2023 – Haynes Convention Center, Boston, Massachusetts
Abstract title: Development of BLX-3030, A Potent, Selective, Orally Available CDK9i shows promise in Pancreatic Ductal Adenocarcinoma (PDAC) Models
Poster number:LB_C13 | Session: Poster Session C
Session location: Level 2, Exhibit Hall D
Session date and time: Saturday, October 14 | 12:30 pm-4:00 pm